Global private equity and venture capital news and research

Posts Tagged ‘Foresite Capital Management’

13 March 2014

OrbiMed helps Sage Therapeutics raise $38m

medical monitor Healthcare-focused investment firm OrbiMed Advisors participated in a $38m Series C round for biopharmaceutical company Sage Therapeutics.

3 July 2013

Foresite Capital leads $30m Series C for biotech group Sequenta

cancer band pink_sq Healthcare focused firm Foresite Capital Management has led a $20m Series C round for biotechnology company Sequenta.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014